
eureKARE
Europe, Ile-de-France, France, Paris
Description
eureKARE is focused on investing in synthetic biology biotechnology companies and creating new ventures.
Investor Profile
eureKARE has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Seed rounds (top funding stages).
- Majority of deals are located in France.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
Stage Focus
- Series C (25%)
- Series B (25%)
- Seed (25%)
- Corporate Round (25%)
Country Focus
- France (100%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Medical
- Genetics
- Neuroscience
- Data Center
- Data Storage
- Electronics
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.